Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 943.45 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 7:06 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by PIRAMAL ENTERPRISES LTD (PIEL) in the last 6 months

Announced 04/1/15
Piramal Clinical Research
Merger/Acquisition

Indoco Remedies Limited (BSE:532612) signed a definitive agreement to acquire Piramal Clinical Research from Piramal Enterprises Limited (BSE:500302) (PEL) in cash on April 1, 2015. The transaction will be funded with internal accruals. Fixed assets of this division along with the employees will be transferred to Indoco on a slump sale basis. The deal is expected to close by April 6, 2015. The transaction does not have a material impact on PEL's balance sheet or profit. ...
Read More


PIEL's price was unchanged after the transaction was announced on 04/1/15.
Investor / Buyer
Indoco Remedies Limited
Creditor / Lender
Piramal Enterprises Limited
 
Announced 01/16/15
25.00M for Coldstream Laboratories Inc.
Merger/Acquisition

Piramal Enterprises Limited (BSE:500302) acquired Coldstream Laboratories Inc. from University Of Kentucky Research Foundation and others for $25 million in cash on January 16, 2015. Piramal Enterprises also paid $5.65 million to acquire the facility building which is currently leased to Coldstream. Sheetal Jobanputra and Candida Pereira of MSL Group acted as public relations advisors to Piramal Enterprises. Lincoln International AG acted as financial advisor to Coldstream ...
Read More


PIEL's price was unchanged after the transaction was announced on 01/16/15.
Investor / Buyer
Piramal Enterprises Limited
Creditor / Lender
University Of Kentucky Research Foundation
Financial Advisor
Lincoln International AG
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PIEL:IN 943.45 INR 0.00

PIEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biocon Ltd 465.80 INR -5.60
Cambrex Corp $40.98 USD -0.75
Divi's Laboratories Ltd 1,894 INR 0.00
Jubilant Life Sciences Ltd 167.45 INR 0.00
Torrent Pharmaceuticals Ltd 1,281 INR 0.00
View Industry Companies
 

Industry Analysis

PIEL

Industry Average

Valuation PIEL Industry Range
Price/Earnings 6.7x
Price/Sales 3.3x
Price/Book 1.4x
Price/Cash Flow 6.0x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PIRAMAL ENTERPRISES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.